Fresenius Medical Care ( (FMS) ) has shared an announcement.
On April 1, 2025, Fresenius Medical Care successfully placed bonds totaling €1.1 billion in two tranches to support general corporate purposes, including refinancing existing financial liabilities. The bonds, issued under the company’s Debt Issuance Program, are expected to be listed on the Luxembourg Stock Exchange, with settlement anticipated on April 8, 2025. This strategic financial move is likely to enhance the company’s liquidity and operational flexibility, reinforcing its market position as a leading provider in the renal care industry.
More about Fresenius Medical Care
Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases, serving approximately 4.2 million patients who regularly undergo dialysis treatment. The company operates a network of 3,675 dialysis clinics globally, providing care for about 299,000 patients. It is also a leading provider of dialysis products such as dialysis machines and dialyzers. Fresenius Medical Care is listed on the Frankfurt Stock Exchange and the New York Stock Exchange.
YTD Price Performance: 12.42%
Average Trading Volume: 290,603
Technical Sentiment Signal: Hold
Current Market Cap: $14.49B
Learn more about FMS stock on TipRanks’ Stock Analysis page.